4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-23-006994
Director acquired 53,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2023-02-02 | Option exercise | +53,000 | $0.45 | $23,850 | 61,193 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2023-02-02 | Option exercise · Stock Option (Right to Buy) | −53,000 | 0 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…